• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Role of Advanced Glycation End-Products in Cancer Disparity.晚期糖基化终产物在癌症差异中的作用。
Adv Cancer Res. 2017;133:1-22. doi: 10.1016/bs.acr.2016.08.001. Epub 2016 Oct 12.
2
Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity.晚期糖基化终产物:一种导致癌症差异的生活方式的生物学后果。
Cancer Res. 2015 May 15;75(10):1925-9. doi: 10.1158/0008-5472.CAN-15-0169. Epub 2015 Apr 28.
3
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.晚期糖基化终产物在雌激素受体阳性乳腺癌患者中升高,改变对治疗的反应,并且可以通过生活方式干预来靶向。
Breast Cancer Res Treat. 2019 Feb;173(3):559-571. doi: 10.1007/s10549-018-4992-7. Epub 2018 Oct 27.
4
AGE metabolites: a biomarker linked to cancer disparity?衰老代谢物:一种与癌症差异相关的生物标志物?
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2186-91. doi: 10.1158/1055-9965.EPI-14-0564. Epub 2014 Jul 22.
5
Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.晚期糖基化终末产物(AGEs)及其受体(RAGE)对癌症代谢信号通路及其进展的影响。
Glycoconj J. 2021 Dec;38(6):717-734. doi: 10.1007/s10719-021-10031-x. Epub 2022 Jan 22.
6
Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications.晚期糖基化终产物在癌症发生中的作用及其治疗意义。
Curr Pharm Des. 2018;24(44):5245-5251. doi: 10.2174/1381612825666190130145549.
7
Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer.饮食和血清晚期糖基化终产物与乳腺癌的临床结局。
Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):188995. doi: 10.1016/j.bbcan.2023.188995. Epub 2023 Oct 6.
8
Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study.晚期糖基化终末产物(AGEs)及其与普通人群中心血管代谢、生活方式和饮食因素的关联:NQplus研究
Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2892. Epub 2017 Apr 17.
9
Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer.细胞外基质糖基化和晚期糖基化终产物受体激活:糖尿病与癌症关联之谜中的缺失一环。
Carcinogenesis. 2018 Apr 5;39(4):515-521. doi: 10.1093/carcin/bgy012.
10
Sex disparity in cardiovascular mortality rates associated with diabetes.糖尿病相关心血管死亡率的性别差异。
Diabetes Metab Res Rev. 2018 Nov;34(8):e3059. doi: 10.1002/dmrr.3059. Epub 2018 Sep 6.

引用本文的文献

1
Association of Dietary Advanced Glycation End Products with Overall and Site-Specific Cancer Risk and Mortality: A Systematic Review and Meta-Analysis.膳食晚期糖基化终产物与总体及特定部位癌症风险和死亡率的关联:一项系统评价和荟萃分析
Nutrients. 2025 May 10;17(10):1638. doi: 10.3390/nu17101638.
2
The Anti-AGEing and RAGEing Potential of Isothiocyanates.异硫氰酸盐的抗衰老和抗晚期糖基化终末产物作用潜力
Molecules. 2024 Dec 19;29(24):5986. doi: 10.3390/molecules29245986.
3
Dietary advanced glycation end-products (dAGEs) are not associated with the risk of cancer incidence. A systematic review and meta-analysis of prospective cohort studies.膳食晚期糖基化终产物(dAGEs)与癌症发病风险无关。一项前瞻性队列研究的系统评价和荟萃分析。
Food Sci Nutr. 2024 Aug 11;12(10):7788-7797. doi: 10.1002/fsn3.4396. eCollection 2024 Oct.
4
Structural basis for FN3K-mediated protein deglycation.FN3K 介导的蛋白质去糖基化的结构基础。
Structure. 2024 Oct 3;32(10):1711-1724.e5. doi: 10.1016/j.str.2024.07.018. Epub 2024 Aug 21.
5
Glycosylation Modulates the Structure and Functions of Collagen: A Review.糖基化修饰调节胶原的结构和功能:综述。
Molecules. 2024 Mar 22;29(7):1417. doi: 10.3390/molecules29071417.
6
Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary gland.青春期摄入饮食中的晚期糖基化终产物会破坏乳腺导管形态发生,并诱导乳腺非典型增生。
Breast Cancer Res. 2023 Oct 6;25(1):118. doi: 10.1186/s13058-023-01714-4.
7
Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.晚期糖基化终末产物、可溶性晚期糖基化终末产物受体和高迁移率族蛋白B1对多发性骨髓瘤临床结局的影响。
Indian J Hematol Blood Transfus. 2023 Apr;39(2):220-227. doi: 10.1007/s12288-022-01574-6. Epub 2022 Oct 17.
8
Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer.晚期糖基化终末产物及其可溶性受体的基因修饰循环水平(AGEs-RAGE轴)与乳腺癌的风险和死亡率
Cancers (Basel). 2022 Dec 12;14(24):6124. doi: 10.3390/cancers14246124.
9
Dietary advanced glycation end products and cancer risk in Japan: From the Takayama study.膳食晚期糖基化终产物与日本癌症风险:来自高山研究。
Cancer Sci. 2022 Aug;113(8):2839-2848. doi: 10.1111/cas.15455. Epub 2022 Jun 25.
10
Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.高级糖基化终产物(AGEs):形成、化学、分类、受体以及与 AGEs 相关的疾病。
Cells. 2022 Apr 12;11(8):1312. doi: 10.3390/cells11081312.

本文引用的文献

1
AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.年龄/晚期糖基化终末产物受体/蛋白激酶B信号通路通过促进视网膜母细胞瘤蛋白磷酸化和降解来促进前列腺癌细胞增殖。
Am J Cancer Res. 2015 Apr 15;5(5):1741-50. eCollection 2015.
2
Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study.氧化应激生物标志物和羧甲基赖氨酸(一种晚期糖基化终产物)对前列腺癌的影响:一项前瞻性研究。
Clin Genitourin Cancer. 2015 Oct;13(5):e347-51. doi: 10.1016/j.clgc.2015.04.004. Epub 2015 Apr 18.
3
Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity.晚期糖基化终产物:一种导致癌症差异的生活方式的生物学后果。
Cancer Res. 2015 May 15;75(10):1925-9. doi: 10.1158/0008-5472.CAN-15-0169. Epub 2015 Apr 28.
4
Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC).欧洲男性和女性总体及腹部肥胖水平下的身体活动与全因死亡率:欧洲癌症与营养前瞻性调查研究(EPIC)
Am J Clin Nutr. 2015 Mar;101(3):613-21. doi: 10.3945/ajcn.114.100065. Epub 2015 Jan 14.
5
Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.在NIH-AARP饮食与健康前瞻性研究中,晚期糖基化终产物的膳食摄入与胰腺癌的关系。
Am J Clin Nutr. 2015 Jan;101(1):126-34. doi: 10.3945/ajcn.114.098061. Epub 2014 Nov 19.
6
Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.晚期糖基化终产物可增加乳腺癌细胞系MDA-MB-231的增殖、迁移和侵袭能力。
Biochim Biophys Acta. 2015 Mar;1852(3):429-41. doi: 10.1016/j.bbadis.2014.12.009. Epub 2014 Dec 13.
7
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.衰老修饰的基底膜与Endo180协同作用,促进上皮细胞侵袭并降低前列腺癌生存率。
J Pathol. 2015 Mar;235(4):581-92. doi: 10.1002/path.4485. Epub 2014 Dec 24.
8
Metformin in cancer prevention and therapy.二甲双胍在癌症预防和治疗中的应用。
Ann Transl Med. 2014 Jun;2(6):57. doi: 10.3978/j.issn.2305-5839.2014.06.01.
9
AGE metabolites: a biomarker linked to cancer disparity?衰老代谢物:一种与癌症差异相关的生物标志物?
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2186-91. doi: 10.1158/1055-9965.EPI-14-0564. Epub 2014 Jul 22.
10
Metformin and cancer: mounting evidence against an association.二甲双胍与癌症:越来越多的证据反对二者存在关联。
Diabetes Care. 2014 Jul;37(7):1786-8. doi: 10.2337/dc14-0500.

晚期糖基化终产物在癌症差异中的作用。

The Role of Advanced Glycation End-Products in Cancer Disparity.

作者信息

Turner D P

机构信息

Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.

出版信息

Adv Cancer Res. 2017;133:1-22. doi: 10.1016/bs.acr.2016.08.001. Epub 2016 Oct 12.

DOI:10.1016/bs.acr.2016.08.001
PMID:28052818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8341423/
Abstract

While the socioeconomic and environmental factors associated with cancer disparity have been well documented, the contribution of biological factors is an emerging field of research. Established disparity factors such as low income, poor diet, drinking alcohol, smoking, and a sedentary lifestyle may have molecular effects on the inherent biological makeup of the tumor itself, possibly altering cell signaling events and gene expression profiles to profoundly alter tumor development and progression. Our understanding of the molecular and biological consequences of poor lifestyle is lacking, but such information may significantly change how we approach goals to reduce cancer incidence and mortality rates within minority populations. In this review, we will summarize the biological, socioeconomic, and environmental associations between a group of reactive metabolites known as advanced glycation end-products (AGEs) and cancer health disparity. Due to their links with lifestyle and the activation of disease-associated pathways, AGEs may represent both a biological consequence and a bio-behavioral indicator of poor lifestyle which may be targeted within specific populations to reduce disparities in cancer incidence and mortality.

摘要

虽然与癌症差异相关的社会经济和环境因素已有充分记录,但生物因素的作用仍是一个新兴的研究领域。诸如低收入、不良饮食、饮酒、吸烟和久坐不动的生活方式等既定的差异因素可能会对肿瘤本身的内在生物学构成产生分子影响,可能改变细胞信号传导事件和基因表达谱,从而深刻改变肿瘤的发展和进程。我们对不良生活方式的分子和生物学后果了解不足,但此类信息可能会显著改变我们实现降低少数族裔人群癌症发病率和死亡率目标的方式。在本综述中,我们将总结一组称为晚期糖基化终产物(AGEs)的反应性代谢物与癌症健康差异之间的生物学、社会经济和环境关联。由于它们与生活方式以及疾病相关途径的激活存在联系,AGEs可能既代表了不良生活方式的生物学后果,也代表了生物行为指标,可针对特定人群进行干预,以减少癌症发病率和死亡率的差异。